Neurology
Generalized Myasthenia Gravis: Treated, but Still Navigating What Comes Next.
KEEP learned from 71 people with confirmed generalized myasthenia gravis in August 2026. Treatment is widespread but control is not: 92% take medication, yet 89% of them describe control as partial or worse, and 94% are limited by weakness or fatigue most weeks. Reassessment is already underway, with 63% discussing a treatment change in the past year. The report shows how to support patients already considering change.
Patient RecruitmentPatient IntelligenceJourney Mapping
Key Highlights
89% on medication report incomplete control
94% limited by weakness or fatigue most weeks
63% discussed a treatment change last year
Overview
71 confirmed gMG patients are treated but not well controlled, already discussing treatment changes, and nearly all open to new therapies.
